switching to semaglutide from tirzepatide vs Semaglutide: Weight Loss, Side Effects, Uses Switching GLP-1 Agonists for MAXIMUM

LBA 59 Sigvardsen, C

DPP-4 inhibitors may be placed in this patient group in those individuals who do not tolerate a treatment with GLP-1 receptor agonists (7072)

Our strengths: Strict quality control: Full GMP management from raw material procurement to finished goods Comprehensive testing: Complete COA (Certificate of Analysis) and SDS (Safety Data Sheet) for every batch Flexible supply: Small samples to large-scale stable supply Professional technical support: Formulation development, stability testing, and regulatory consulting We understand that choosing the right raw material is the first step to product success

217 , e20190613 (2020)